CELLEBRITE DI LTD (CLBT) Stock Fundamental Analysis
NASDAQ:CLBT - IL0011794802 - Common Stock
16.4 USD
-0.31 (-1.86%)
16.4 USD
0 (0%)
Taking everything into account, CLBT scores 5 out of 10 in our fundamental rating. CLBT was compared to 280 industry peers in the Software industry. CLBT is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. While showing a medium growth rate, CLBT is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
CLBT had positive earnings in the past year.
In the past year CLBT had a positive cash flow from operations.
In multiple years CLBT reported negative net income over the last 5 years.
CLBT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CLBT has a worse Return On Assets (-19.17%) than 71.07% of its industry peers.
CLBT's Return On Equity of -36.96% is on the low side compared to the rest of the industry. CLBT is outperformed by 64.29% of its industry peers.
The Return On Invested Capital of CLBT (10.23%) is better than 86.07% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CLBT is below the industry average of 12.00%.
The last Return On Invested Capital (10.23%) for CLBT is above the 3 year average (7.06%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -19.17% | ||
| ROE | -36.96% | ||
| ROIC | 10.23% |
ROA(3y)-9.14%
ROA(5y)-1.85%
ROE(3y)-54.72%
ROE(5y)N/A
ROIC(3y)7.06%
ROIC(5y)7.59%
1.3 Margins
CLBT has a better Operating Margin (14.16%) than 80.00% of its industry peers.
CLBT's Operating Margin has improved in the last couple of years.
CLBT has a Gross Margin of 84.38%. This is amongst the best in the industry. CLBT outperforms 91.79% of its industry peers.
CLBT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.16% | ||
| PM (TTM) | N/A | ||
| GM | 84.38% |
OM growth 3Y10.9%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.66%
GM growth 5Y1.3%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CLBT is creating some value.
CLBT has more shares outstanding than it did 1 year ago.
CLBT has more shares outstanding than it did 5 years ago.
There is no outstanding debt for CLBT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 7.38 indicates that CLBT is not in any danger for bankruptcy at the moment.
CLBT has a better Altman-Z score (7.38) than 80.00% of its industry peers.
There is no outstanding debt for CLBT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 7.38 |
ROIC/WACC1.12
WACC9.15%
2.3 Liquidity
CLBT has a Current Ratio of 1.96. This is a normal value and indicates that CLBT is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.96, CLBT is doing good in the industry, outperforming 61.07% of the companies in the same industry.
CLBT has a Quick Ratio of 1.92. This is a normal value and indicates that CLBT is financially healthy and should not expect problems in meeting its short term obligations.
CLBT has a better Quick ratio (1.92) than 60.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.96 | ||
| Quick Ratio | 1.92 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 16.75% over the past year.
CLBT shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.48%.
Measured over the past years, CLBT shows a quite strong growth in Revenue. The Revenue has been growing by 18.47% on average per year.
EPS 1Y (TTM)16.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
Revenue 1Y (TTM)20.48%
Revenue growth 3Y17.68%
Revenue growth 5Y18.47%
Sales Q2Q%18.35%
3.2 Future
The Earnings Per Share is expected to grow by 12.94% on average over the next years. This is quite good.
Based on estimates for the next years, CLBT will show a quite strong growth in Revenue. The Revenue will grow by 15.18% on average per year.
EPS Next Y17.86%
EPS Next 2Y12.72%
EPS Next 3Y12.96%
EPS Next 5Y12.94%
Revenue Next Year17.76%
Revenue Next 2Y17.22%
Revenue Next 3Y17.04%
Revenue Next 5Y15.18%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 35.65, CLBT can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of CLBT indicates a somewhat cheap valuation: CLBT is cheaper than 61.79% of the companies listed in the same industry.
CLBT's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.13.
CLBT is valuated quite expensively with a Price/Forward Earnings ratio of 30.73.
Based on the Price/Forward Earnings ratio, CLBT is valued a bit cheaper than the industry average as 62.50% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.76, CLBT is valued a bit more expensive.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.65 | ||
| Fwd PE | 30.73 |
4.2 Price Multiples
65.36% of the companies in the same industry are more expensive than CLBT, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CLBT is valued a bit cheaper than 75.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 26.91 | ||
| EV/EBITDA | 44.79 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CLBT does not grow enough to justify the current Price/Earnings ratio.
CLBT's earnings are expected to grow with 12.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)2
PEG (5Y)N/A
EPS Next 2Y12.72%
EPS Next 3Y12.96%
5. Dividend
5.1 Amount
No dividends for CLBT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
16.4
-0.31 (-1.86%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners42.46%
Inst Owner Change5.47%
Ins Owners2.71%
Ins Owner ChangeN/A
Market Cap4.01B
Analysts84.29
Price Target23.46 (43.05%)
Short Float %2.99%
Short Ratio1.99
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.37%
Min EPS beat(2)12.81%
Max EPS beat(2)15.93%
EPS beat(4)4
Avg EPS beat(4)21.79%
Min EPS beat(4)0.93%
Max EPS beat(4)57.51%
EPS beat(8)8
Avg EPS beat(8)51.82%
EPS beat(12)11
Avg EPS beat(12)53.22%
EPS beat(16)13
Avg EPS beat(16)50.32%
Revenue beat(2)0
Avg Revenue beat(2)-2.3%
Min Revenue beat(2)-3.58%
Max Revenue beat(2)-1.03%
Revenue beat(4)1
Avg Revenue beat(4)-0.52%
Min Revenue beat(4)-3.58%
Max Revenue beat(4)2.78%
Revenue beat(8)5
Avg Revenue beat(8)0.93%
Revenue beat(12)7
Avg Revenue beat(12)0.54%
Revenue beat(16)9
Avg Revenue beat(16)0.41%
PT rev (1m)-8%
PT rev (3m)-15.85%
EPS NQ rev (1m)1.51%
EPS NQ rev (3m)5.16%
EPS NY rev (1m)5.76%
EPS NY rev (3m)5.76%
Revenue NQ rev (1m)-1.58%
Revenue NQ rev (3m)-3.61%
Revenue NY rev (1m)-0.98%
Revenue NY rev (3m)-0.98%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.65 | ||
| Fwd PE | 30.73 | ||
| P/S | 9.18 | ||
| P/FCF | 26.91 | ||
| P/OCF | 24.89 | ||
| P/B | 9.82 | ||
| P/tB | 10.85 | ||
| EV/EBITDA | 44.79 |
EPS(TTM)0.46
EY2.8%
EPS(NY)0.53
Fwd EY3.25%
FCF(TTM)0.61
FCFY3.72%
OCF(TTM)0.66
OCFY4.02%
SpS1.79
BVpS1.67
TBVpS1.51
PEG (NY)2
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -19.17% | ||
| ROE | -36.96% | ||
| ROCE | 12.96% | ||
| ROIC | 10.23% | ||
| ROICexc | 926.92% | ||
| ROICexgc | N/A | ||
| OM | 14.16% | ||
| PM (TTM) | N/A | ||
| GM | 84.38% | ||
| FCFM | 34.12% |
ROA(3y)-9.14%
ROA(5y)-1.85%
ROE(3y)-54.72%
ROE(5y)N/A
ROIC(3y)7.06%
ROIC(5y)7.59%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.94%
ROCE(5y)9.6%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y10.9%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.66%
GM growth 5Y1.3%
F-Score5
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 114.28% | ||
| Cap/Sales | 2.77% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 222.39% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.96 | ||
| Quick Ratio | 1.92 | ||
| Altman-Z | 7.38 |
F-Score5
WACC9.15%
ROIC/WACC1.12
Cap/Depr(3y)92.67%
Cap/Depr(5y)99.76%
Cap/Sales(3y)2.81%
Cap/Sales(5y)2.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
EPS Next Y17.86%
EPS Next 2Y12.72%
EPS Next 3Y12.96%
EPS Next 5Y12.94%
Revenue 1Y (TTM)20.48%
Revenue growth 3Y17.68%
Revenue growth 5Y18.47%
Sales Q2Q%18.35%
Revenue Next Year17.76%
Revenue Next 2Y17.22%
Revenue Next 3Y17.04%
Revenue Next 5Y15.18%
EBIT growth 1Y23.19%
EBIT growth 3Y30.51%
EBIT growth 5YN/A
EBIT Next Year30.19%
EBIT Next 3Y22.99%
EBIT Next 5Y19.13%
FCF growth 1Y160.75%
FCF growth 3Y63.25%
FCF growth 5Y65.07%
OCF growth 1Y150.74%
OCF growth 3Y54.2%
OCF growth 5Y52.3%